Trial intelligence / Profile preview

Pitavastatin vs Atorvastatin in Type 2 Diabetes with Combined Dyslipidemia

NCT00309751Phase 3Completed

Sponsor
Kowa Company, Ltd.
Start
Dec 2005
Primary completion
Jun 2007
Modality
Small Molecules
Countries
6
01

Overview

A Phase 3 trial of pitavastatin in combined dyslipidemia, sponsored by Kowa Company, Ltd.. Started Dec 2005; status: completed.

02

Drugs

pitavastatin
03

Conditions

combined dyslipidemia

Beyond the preview

Go deeper on NCT00309751.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00309751.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call